CSA Medical completes enrolment in chronic bronchitis trial
CSA Medical has completed enrolment in its SPRAY-CB trial (NCT03893370) for patients with chronic obstructive pulmonary disease (COPD) with chronic…
CSA Medical has completed enrolment in its SPRAY-CB trial (NCT03893370) for patients with chronic obstructive pulmonary disease (COPD) with chronic…
Immorna Biotherapeutics investigational new drug (IND) application for a Phase I/II study of its cancer therapeutic JCXH-211 intravenous (IV) has…
Edinburgh University spin-out Resolution Therapeutics has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to initiate…
India-headquartered Sun Pharmaceutical Industries has announced significant weight loss and lipid level reductions in a study evaluating its investigational drug…
Zealand Pharma believes its weight loss drug petrelintide could be comparable to glucagon like peptide-1 receptor agonists (GLP1-RAs) while providing…
A five drug combination drug therapy trial has shown substantial tumour shrinking in more than half of patients, with some…
AstraZeneca has been dealt a blow after its flagship breast cancer drug Truqap (capivasertib) did not improve overall survival (OS)…
The US Food and Drug Administration (FDA) has placed a partial clinical hold on BioNTech’s Phase I trial evaluating the…
Shanghai based-biotech company CARsgen Therapeutics has announced that its CAR T cell candidate CT071 has shown early signs of efficacy…
Denmark-based pharmaceutical company Union Therapeutics has shared data from its ADESOS Phase 2b study evaluating orismilast as an oral treatment…